Anxiety-like behavior induced by IL-1β is modulated by α-MSH through central melanocortin-4 receptors

Peptides

Volumn 27, Issue 6, 2006, Pages 1451-1456

  Cragnolini, Andrea Beatríz ^a   Schiöth, Helgi Birgir ^b   Scimonelli, Teresa Nieves ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

MSH; MSH; Anxiety like behavior; IL 1 ; Melanocortin receptors

Indexed keywords

ALPHA INTERMEDIN; BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; GAMMA INTERMEDIN; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MW 15129; MW 1664; RECOMBINANT INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-MSH; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; GAMMA-MSH; INTERLEUKIN-1; MALE; MAZE LEARNING; NEUROPEPTIDES; PEPTIDES; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 33646930047     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.10.020     Document Type: Article

References (39)

1. Adamec R.E., Sayin U., and Brown A. The effects of corticotropin releasing factor (CRH) and handling stress on behavior in the elevated plus-maze of anxiety. J Psychopharmac 5 (1991) 175-186
2. Adan R.A., and Gispen W.H. Brain melanocortin receptors: from cloning to function. Peptides 18 (1997) 1279-1287
3. Anisman H., and Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 461 (1999) 199-233
4. Berkenbosch F., de Goeij D.E., Rey A.D., and Besedovsky H.O. Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology 50 (1989) 570-576
5. Berkenbosch F., van Oers J., del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-526
6. Bluthe R.M., Dantzer R., and Kelley K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res 573 (1992) 318-320
7. Catania A., and Lipton J.M. α-Melanocyte stimulating hormone in the modulation of host reactions. Endocrine Rev 14 (1993) 564-576
8. Catania A., and Lipton J.M. Peptide modulation of fever and inflammation within the brain. Ann N Y Acad Sci 62 (1998) 856-862
9. Ceriani G., Macaluso A., Catania A., and Lipton J.M. Central neurogenic antiinflammatory action of alpha-MSH: modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology 59 (1994) 138-143
10. Connor T.J., Song C., Leonard B.E., Merali Z., and Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84 (1998) 923-933
11. Cragnolini A., Perello M., Schiöth H., and Scimonelli T. alpha-MSH and gamma-MSH inhibit IL-1beta induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors. Regul Pept 122 (2004) 185-190
12. Dantzer R., Bluthé R.M., Castanon N., Chauvet N., Capuron L., Goodall G., et al. Cytokine effects on behavior Psychoneuroimmunology. 3rd ed. (2001), Academic Press, New York p. 703-27
13. Dawson G., and Triklebak M. Use of the elevated plus maze in the search for a novel axiolytic agents. TipS 16 (1995) 33-36
14. Fiore M., Alleva E., Probert L., Kollias G., Angelucci F., and Aloe L. Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha. Physiol Behav 63 (1998) 571-576
15. Gonzalez M.I., Vaziri S., and Wilson C.A. Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides 17 (1996) 171-177
16. Gonzalez M.I., Baker B.I., Hole D.R., and Wilson C.A. Behavioral effects of Neuropeptide E-I (NEI) in the female rat: interactions with alpha-MSH MCH and Dopamine. Peptides 19 (1998) 1007-1016
17. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54 (1996) 21-30
18. Huh S.K., Lipton J.M., and Batjer H.H. The protective effect of α-melanocyte-stimulating hormone on canine brain stem ischemia. Neurosurgery 40 (1997) 132-140
19. Kishi T., Aschkenasi C.J., Lee C.E., Mountjoy K.G., Saper C.B., and Elmquist J.K. Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 457 (2003) 213-235
20. Kokare D.M., Dandekar M.P., Chopde C.T., and Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Res 1043 (2005) 107-114
21. Konda Y., Gantz I., DelValle J., Shimoto Y., Miwa H., and Yamada T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J Biol Chem 269 (1994) 13162-13166
22. Lawrence C.B., and Rothwell N.J. Anorexic but not pyrogenic actions of Interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat. J Neuroendocrinol 13 (2001) 490-495
23. Lindblom J., Schiöth H.B., Larsson A., Wikberg J., and Bergström L. Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain. Brain Res 810 (1998) 161-171
24. Lyson K., and McCann S.M. Alpha-melanocyte-stimulating hormone abolishes IL-1- and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 58 (1993) 191-195
25. Macaluso A., McCoy D., Ceriani G., Watanabe T., Biltz J., Catania A., et al. Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions. J Neurosci 14 (1994) 2377-2382
26. Millan M. The neurobiology and control of anxious states. Progress Neurobiol 70 (2003) 83-244
27. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., and Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8 (1994) 1298-1308
28. Patchev V.K., Shoaib M., Holsboer F., and Almeida O.F. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience 62 (1994) 265-271
29. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press, 1986, Fig. 21.
30. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
31. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24 (1986) 525-529
32. Raber J., Koob G.F., and Bloom F.E. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 272 (1995) 815-824
33. Rao T.L., Kokare D.M., Sarkar S., Khisti R.T., Chopde C.T., and Subhedar N. GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats. Pharmacol Biochem Behav 76 (2003) 417-423
34. Robertson B., Dostal K., and Daynes R.A. Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses. J Immunol 140 (1988) 4300-4307
35. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90 (1993) 8856-8860
36. Schiöth H.B., Mutulis F., Muceniece R., Prusis P., and Wikberg J.E.S. Discovery of novel melanocortin 4 receptor selective MSH analogues. Br J Pharmacol 124 (1998) 75-82
37. Schiöth H.B. The physiological role of melanocortin receptors. Vitam Horm 63 (2001) 195-232
38. Schrott L.M., and Crnic L.S. Increased anxiety behaviors in autoimmune mice. Behav Neurosci 110 (1996) 492-502
39. Tatro J.B. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation 3 (1996) 259-284